ClinicalTrials.gg
DrugSupplement

Niacinamide clinical trials

Also written Nicotinamide.

studies test it
65
open now
18
in phase 3
10
first study started
2000

How each study uses Niacinamide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Niacinamide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Jul 1947 · BEROCCA PN · NDA 006071 (FDA, Drugs@FDA; in a combination)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Niacinamide
21
Vitamin B3
6
Nicotinamide (NAM)
4
Nicotinamide Tablet
3
Oral Nicotinamide
2

Other names

Nicotinamide
33
Nicotinamide 1000 mg
2
Nicotinamide 500 mg
1

In one entry with another drug

Given together, or one or the other

Vitamin B3
4

Studies by the year they started

64 studies that test it; most in 2026 (7); 1 more planned to start later

Studies that test Niacinamide, by start year
YearStudies
20001
20041
20062
20082
20103
20112
20121
20142
20155
20164
20174
20181
20193
20203
20216
20225
20235
20244
20253
20267

By phase

A phase 1/2 study counts in both.

Early Phase 1
6
Phase 1
11
Phase 2
26
Phase 3
10
Phase 4
3
No phase
15

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 5 · Other 60

Ain Shams University (3) · University of California, Irvine (2) · Umeå University (2) · University of North Carolina, Chapel Hill (2) · Columbia University (2) · Rhode Island Hospital (2) · Federal University of São Paulo (2) · Universidad Autonoma de San Luis Potosí (2)

Often tested with

Tested in the same studies.

Niacin (7) · Lanthanum carbonate (2) · Pyruvic Acid (2) · Maraviroc (2) · Dolutegravir (2) · Dendritic Cell Vaccine (2) · Auranofin (2) · Creatine (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 9, 2 in phase 3

Studies that test Niacinamide, phase 3 first.

Studies

Open first, then newest update. How each study uses Niacinamide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 65

See all 65 studies that test Niacinamide →

Given beside what is tested · 2 — Niacinamide is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Niacinamide

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Niacinamide · ClinicalTrials.gg INT007887

  • MeSH (NLM) D009536NiacinamideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 25X51I8RD4NIACINAMIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 7405Confirmed FDA, Wikidata
  • Wikidata Q192423niacinamideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C2327NiacinamideOne source FDA
  • DrugBank DB02701One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.